Search research articles
Contact Us
Filters
Showing results (211-220 of 268) with videos related to
Page
of 27
Sort By:
Cancer Discovery
|
August 21, 2014
Brain tumor cells in circulation are enriched for mesenchymal gene expression
James P Sullivan, Brian V Nahed, Marissa W Madden, et al.
Nature Medicine
|
April 6, 2023
Tumor inflammation-associated neurotoxicity
Jasia Mahdi, Jorg Dietrich, Karin Straathof, et al.
Nature Reviews. Clinical Oncology
|
December 9, 2024
Leptomeningeal metastatic disease: new frontiers and future directions
Ahmad Ozair, Hannah Wilding, Debarati Bhanja, et al.
Neuro-Oncology
|
April 5, 2013
Phase 2 study of dose-intense temozolomide in recurrent glioblastoma
Andrew D Norden, Glenn J Lesser, Jan Drappatz, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 5, 2016
Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages
Teresa E Peterson, Nathaniel D Kirkpatrick, Yuhui Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 29, 2017
Diffusion MRI Phenotypes Predict Overall Survival Benefit from Anti-VEGF Monotherapy in Recurrent Glioblastoma: Converging Evidence from Phase II Trials
Benjamin M Ellingson, Elizabeth R Gerstner, Marion Smits, et al.
Neuro-Oncology
|
December 8, 2021
Clinical utility of targeted next-generation sequencing assay in IDH-wildtype glioblastoma for therapy decision-making
Mary Jane Lim-Fat, Gilbert C Youssef, Mehdi Touat, et al.
Neuro-Oncology
|
February 9, 2021
Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG)
Ramon F Barajas, Letterio S Politi, Nicoletta Anzalone, et al.
Cancer Cell
|
January 16, 2007
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients
Tracy T Batchelor, A Gregory Sorensen, Emmanuelle di Tomaso, et al.
Blood
|
July 15, 2025
Clinical presentation, management, and outcome of TIAN in CNS lymphoma treated with CD19-CAR T-cell Therapy
Leon D Kaulen, Maria Martinez-Lage, Jeremy S Abramson, et al.
Page
of 27
Search research articles
Search
Showing results (211-220 of 268) with videos related to
Sort By:
Page
of 27
Cancer Discovery
|
August 21, 2014
Brain tumor cells in circulation are enriched for mesenchymal gene expression
James P Sullivan, Brian V Nahed, Marissa W Madden, et al.
Nature Medicine
|
April 6, 2023
Tumor inflammation-associated neurotoxicity
Jasia Mahdi, Jorg Dietrich, Karin Straathof, et al.
Nature Reviews. Clinical Oncology
|
December 9, 2024
Leptomeningeal metastatic disease: new frontiers and future directions
Ahmad Ozair, Hannah Wilding, Debarati Bhanja, et al.
Neuro-Oncology
|
April 5, 2013
Phase 2 study of dose-intense temozolomide in recurrent glioblastoma
Andrew D Norden, Glenn J Lesser, Jan Drappatz, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 5, 2016
Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages
Teresa E Peterson, Nathaniel D Kirkpatrick, Yuhui Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 29, 2017
Diffusion MRI Phenotypes Predict Overall Survival Benefit from Anti-VEGF Monotherapy in Recurrent Glioblastoma: Converging Evidence from Phase II Trials
Benjamin M Ellingson, Elizabeth R Gerstner, Marion Smits, et al.
Neuro-Oncology
|
December 8, 2021
Clinical utility of targeted next-generation sequencing assay in IDH-wildtype glioblastoma for therapy decision-making
Mary Jane Lim-Fat, Gilbert C Youssef, Mehdi Touat, et al.
Neuro-Oncology
|
February 9, 2021
Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG)
Ramon F Barajas, Letterio S Politi, Nicoletta Anzalone, et al.
Cancer Cell
|
January 16, 2007
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients
Tracy T Batchelor, A Gregory Sorensen, Emmanuelle di Tomaso, et al.
Blood
|
July 15, 2025
Clinical presentation, management, and outcome of TIAN in CNS lymphoma treated with CD19-CAR T-cell Therapy
Leon D Kaulen, Maria Martinez-Lage, Jeremy S Abramson, et al.
Page
of 27